2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Kahler Disease in 1 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mutlu, P | 1 |
| Baran, Y | 1 |
| Ural, AU | 1 |
| Avcu, F | 1 |
| Dirican, B | 1 |
| Beyzadeoglu, M | 1 |
| Gündüz, U | 1 |
1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Kahler Disease
| Article | Year |
|---|---|
Effect of cobalt-60 (γ radiation) on multidrug-resistant multiple myeloma cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cobalt Radioisotopes; Drug Resistance, | 2011 |